This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Ivoclar Vivadent Ag, Sartorius Stedim Biotech Gmbh, Stitftung für Lasertechnologien in Der Medizin Und Me Technik an Der Universität Ulm. Active years: 2026.
Company Filing History:


Years Active: 2026
Title: Steffen Nothelfer - Innovator in Biological Cell Analysis
Introduction
Steffen Nothelfer is an inventor based in Nersingen, Germany. He is associated with Ivoclar Vivadent AG, a company known for its contributions to dental materials and technologies. Although he currently holds no granted patents, his work in the field of biological cell analysis is noteworthy.
Latest Patent Applications
Steffen Nothelfer has submitted several innovative patent applications. One of his latest applications is titled "Device and Method for Determining a Viability and/or a Cell Count of Biological Cells in a Suspension by Means of Collimated Transmission." This application describes devices and methods for assessing the viability and cell counts of biological cells in a suspension culture using collimated transmission. The devices include an illumination source for generating an electromagnetic illumination beam, beam manipulation means for collimating the illumination beam, and a detection unit for detecting an electromagnetic transmission beam that has been transmitted through a sample of the cell suspension culture.
Another significant application is "Method For Detecting Demineralization Of Tooth Substance." This method involves irradiating a structured light pattern onto the tooth substance, detecting the light intensity of the remitted light pattern, and determining the demineralization of the tooth substance based on the detected light intensity.
Conclusion
Steffen Nothelfer's contributions to the field of biological cell analysis through his innovative patent applications highlight his potential as an inventor. His work at Ivoclar Vivadent AG and his focus on developing methods for assessing cell viability and tooth substance demineralization demonstrate his commitment to advancing technology in healthcare.